Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
· cnbc.com
Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.
Two employees in pharmaceutical industry wearing protective gloves, mask, cap and white suit seen standing by the machine that is the part of the medicaments pr...